IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $252,000 | -11.3% | 24,400 | +58.4% | 0.02% | -23.3% |
| Q3 2018 | $284,000 | +142.7% | 15,400 | +43.6% | 0.03% | +400.0% |
| Q1 2016 | $117,000 | -87.7% | 10,725 | -86.9% | 0.01% | -85.0% |
| Q4 2015 | $948,000 | -82.9% | 81,762 | -77.3% | 0.04% | -82.9% |
| Q2 2014 | $5,530,000 | -90.3% | 360,724 | -92.2% | 0.23% | -90.1% |
| Q1 2014 | $57,192,000 | -3.1% | 4,642,182 | -8.7% | 2.35% | -7.6% |
| Q4 2013 | $59,037,000 | +3.9% | 5,084,999 | +5.9% | 2.55% | -6.9% |
| Q3 2013 | $56,830,000 | +12.4% | 4,799,848 | -5.7% | 2.73% | +82.9% |
| Q2 2013 | $50,544,000 | – | 5,090,047 | – | 1.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |